1. Home
  2. BOLT vs NTIP Comparison

BOLT vs NTIP Comparison

Compare BOLT & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • NTIP
  • Stock Information
  • Founded
  • BOLT 2015
  • NTIP 1990
  • Country
  • BOLT United States
  • NTIP United States
  • Employees
  • BOLT N/A
  • NTIP N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • NTIP Multi-Sector Companies
  • Sector
  • BOLT Health Care
  • NTIP Miscellaneous
  • Exchange
  • BOLT Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • BOLT 25.3M
  • NTIP 29.5M
  • IPO Year
  • BOLT 2021
  • NTIP 1998
  • Fundamental
  • Price
  • BOLT $0.57
  • NTIP $1.33
  • Analyst Decision
  • BOLT Hold
  • NTIP
  • Analyst Count
  • BOLT 5
  • NTIP 0
  • Target Price
  • BOLT $1.25
  • NTIP N/A
  • AVG Volume (30 Days)
  • BOLT 126.9K
  • NTIP 49.6K
  • Earning Date
  • BOLT 11-12-2024
  • NTIP 10-24-2024
  • Dividend Yield
  • BOLT N/A
  • NTIP 7.41%
  • EPS Growth
  • BOLT N/A
  • NTIP N/A
  • EPS
  • BOLT N/A
  • NTIP N/A
  • Revenue
  • BOLT $9,779,000.00
  • NTIP $1,881,000.00
  • Revenue This Year
  • BOLT $16.30
  • NTIP N/A
  • Revenue Next Year
  • BOLT N/A
  • NTIP N/A
  • P/E Ratio
  • BOLT N/A
  • NTIP N/A
  • Revenue Growth
  • BOLT 35.86
  • NTIP 129.39
  • 52 Week Low
  • BOLT $0.55
  • NTIP $1.24
  • 52 Week High
  • BOLT $1.56
  • NTIP $2.25
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 29.99
  • NTIP 50.04
  • Support Level
  • BOLT $0.63
  • NTIP $1.29
  • Resistance Level
  • BOLT $0.69
  • NTIP $1.34
  • Average True Range (ATR)
  • BOLT 0.03
  • NTIP 0.04
  • MACD
  • BOLT -0.01
  • NTIP 0.01
  • Stochastic Oscillator
  • BOLT 3.49
  • NTIP 76.56

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: